BioCardia, Inc.(NASDAQ : BCDA)
Volume Open Day's Low Day's High 52 Wk Low 52 Wk High Bid Ask EPS PE Ratio Shares Market Cap Dividend Ex-Div Date Yield
Interested in Binary Options?
We'll teach you the best ways to trade binaries.
Health Technology » Biotechnology
|SNSS||Sunesis Pharmaceuticals, Inc.||3.75%||6.37||0.7%||$445.29m|
|REGN||Regeneron Pharmaceuticals, Inc.||1.55%||560.67||2.7%||$438.27m|
|GILD||Gilead Sciences, Inc.||0.29%||67.10||1.0%||$414.29m|
|XLRN||Acceleron Pharma, Inc.||-0.48%||172.90||5.3%||$348.63m|
|VRTX||Vertex Pharmaceuticals, Inc.||0.36%||186.08||1.9%||$270.73m|
|XENE||Xenon Pharmaceuticals, Inc.||2.11%||30.44||0.4%||$163.76m|
|CRSP||CRISPR Therapeutics AG||-1.75%||98.51||0.6%||$159.29m|
BioCardia, Inc. operates as a clinical-stage regenerative medicine company. It develops novel therapeutics for cardiovascular diseases. The firm offers proprietary comprehensive biotherapeutic solutions for cardiovascular disease under the CardiAMP and CardiALLO brand. It operates in only one business segment, which is a clinical-stage regenerative medicine company developing novel therapeutics for cardiovascular diseases with large unmet medical needs. The company was founded on January 12, 1994 and is headquartered in San Carlos, CA.